Investment Summary |
|
|---|---|
| Date | 2012-03-15 |
| Target | MedPricer.com |
| Sector | Healthcare Services |
| Investor(s) | Telegraph Hill Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 2001 |
| Size | Middle-Market |
| Type | Sector Focused |
Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 18 of 34 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Venture M&A Deals | 12 of 20 |
| State: Connecticut M&A | 1 of 1 |
| Country: United States M&A | 18 of 31 |
| Year: 2012 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-02-22 |
Freedom Innovations
Irvine, California, United States Freedom Innovations designs and manufactures advanced technology lower-limb prosthetic devices geared towards amputees with active lifestyles. The Company manufactures its products using 100% carbon-fiber composite materials, maximizing strength and energy return while minimizing weight. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-08-21 |
RareCyte
Seattle, Washington, United States RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. RareCyte was founded in 2009 and is based in Seattle, Washington. |
Buy | - |
